Cor Vasa 2009, 51(6):425-426 | DOI: 10.33678/cor.2009.108

Treatment of depression and anxiety disorder after stroke or TIA

Milan Vrána*, Radkin Honzák1
1 Psychiatrická katedra IPVZ, Praha, Česká republika

A proportion of patients after a stroke and transitory ischemic attack (TIA) experiences depression or anxiety. The aim of our study was to test treatment of depression/anxiety with the antidepressant paroxetine in these patients. We retrospectively evaluated outcomes in two subgroups of patients taken out from the basic series of the PrevenPar project. One subgroup included patients after a previous stroke, the other one embraced patients who had had TIA.
One-year treatment with the antidepressant paroxetine at an average dose of 20 mg completely suppressed the symptoms of moderate to severe depression/anxiety. Subsets of patients free of symptoms of depression/anxiety formed in either patient subgroup. It addition to being successful, paroxetine-based treatment was also safe. The authors review the possibility of incorporating the diagnosis and treatment of depression/anxiety into guidelines of Czech professional societies.

Keywords: Stroke; Transitory ischemic attack; Depression; Anxiety; Treatment with the antidepressant paroxetine; Guidelines of Czech societies

Published: June 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vrána M, Honzák R. Treatment of depression and anxiety disorder after stroke or TIA. Cor Vasa. 2009;51(6):425-426. doi: 10.33678/cor.2009.108.
Download citation

References

  1. Bruthans J, Mayer O jr., Šimon J, a spol. Úroveň sekundární prevence cévních mozkových příhod u českých pacientů ve studii EUROASPIRE III - Stroke Specific Module. Cor Vasa 2008;50:446-54. Go to original source...
  2. Hackett ML, Yapa Ch, Parag V, et al. Frequency of depression after stroke: A systematic of observational studies. Stroke 2005;36:1330-40. Go to original source... Go to PubMed...
  3. Huffman J, Stern TA. Acute psychiatric manifestations of stroke. A clinical case conference. Psyschosomatic 2003;44:65-75. Go to original source... Go to PubMed...
  4. Salaycik KJ, Kelly-Hayes M, Beiser A, et al. Depressive symptoms and risk of stroke: The Framingham Study. Stroke 2007;38:16-21. Go to original source... Go to PubMed...
  5. Jia H, Damush TM, Quin H, et al. The impact of poststroke depression on healthcare use by veterans with acute stroke. Stroke 2006;37:2796-801. Go to original source... Go to PubMed...
  6. Erikson M, Asplund K, Glader EL, et al. Self reported depression and use of antidepressants after stroke: A National Survey. Stroke 2004;35:936-41. Go to original source... Go to PubMed...
  7. Lichtman JH, Bigger T, Blumenthal JA, et al. Depression and coronary heart disease: Recommendations for screening, referral and treatment. Circulation 2008;118:1768-75. Go to original source... Go to PubMed...
  8. Vrána M. Prevence kardiovaskulárních komplikací paroxetinem u osob s ischemickou chorobou srdeční a s depresivní nebo úzkostnou poruchou. Projekt PrevenPar. Cor Vasa 2007;49:147-51. Go to original source...
  9. Vrána M, Honzák R. Léčba depresivní a úzkostné poruchy při ischemické chorobě srdeční. Cor Vasa 2008;50:338-42. Go to original source...
  10. Kalita Z, Keller O, Bar M, et al. Doporučený postup sekundární prevence u ischemických cévních mozkových příhod. Česká neurologická společnost 2008. www.czech-neuro.cz.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.